Binhui Biopharmaceutical raised the strategic investment from Yangzi River Pharmaceutical, supporting the development of oncolytic virotherapy

Author:bhsw  Date:2021-09-29 08:22:33  Views:

Binhui Biopharmaceutical Co., Ltd., a leading company in oncolytic virotherapy in China, and Yangzi River Pharmaceutical Group, a leading pharmaceutical company in China, have reached a strategic collaboration on September 29, 2021, announcing a closer collaboration in the field of biomedicine.